Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16

February 13, 2011 10:33 pm | by Bio-Medicine.Org | News | Comments

SEATTLE, Feb. 14, 2011 /- On Wednesday, February 16, 2011, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the Company's 2010 fourth quarter and...

Ultrasound Industry Expert, Chris Daft, Joins Samplify Systems

February 13, 2011 5:33 pm | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., Feb. 13, 2011 /- Samplify Systems, Inc., a leading provider of technology, semiconductors and sub-systems for the ultrasound equipment market, announced today that Chris Daft, Ph.D. has joined the company as Senior Scientist, where he will apply his expertise to...

ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts(2)

February 12, 2011 5:33 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 12, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it will hold a conference call on Monday, February 14th, 2011 at 8:30am Eastern Time to provide an update regarding its pipeline expansion efforts. Interested parties may access the...

Advertisement

Innophos Holdings, Inc. Announces Annual Meeting

February 11, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

CRANBURY, N.J., Feb. 11, 2011 /- Innophos Holdings, Inc. (Nasdaq: IPHS ) today announced that its annual meeting of stockholders will take place on Friday, May 20, 2011 in Jamesburg, New Jersey.  The record date for the stockholders entitled to vote at the meeting has been fixed as...

Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing

February 11, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 11, 2011 /- Conatus Pharmaceuticals Inc. today announced the closing of a $20 million Series B Preferred Stock private placement financing.  This financing was led by new investor, AgeChem Venture Fund of Montreal, Canada, and included participation by existing...

Sports Icon Billie Jean King Gets Back in the Game with Help from New Knees

February 11, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Feb. 11, 2011 /- Today, Smith & Nephew, Inc. (LSE: SN; NYSE: SNN ) announced it is partnering with famed sports icon and humanitarian Billie Jean King to highlight her success following her double knee replacement with a Smith & Nephew product. One year ago, King...

Mindray to Report Fourth Quarter and Full Year 2010 Financial Results on February 28, 2011(2)

February 11, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Feb. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the fourth quarter ended December 31,...

Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System

February 11, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

MAHWAH, N.J., Feb. 11, 2011 /- Stryker Corporation's (NYSE: SYK ) Orthopaedics Division today announced U.S. Food and Drug Administration 510(k) clearance for its MDM X3 Modular Dual Mobility Mobile Bearing Hip System.  MDM X3 is an addition to the company's portfolio of...

Advertisement

Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing

February 11, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NANJING, China, Feb. 11, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced...

USDA Recognizes Benefit of Supplements in New Dietary Guidelines But Doesn't Go Far Enough

February 10, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Feb. 10, 2011 /- USANA Health Sciences, Inc. (NYSE: USNA ) commends the USDA for recognizing that nutritional gaps are common in the average American diet and that dietary supplementation can play a vital role in filling those gaps.  However, USANA scientists and...

PeriGen, Inc. Forms Strategic Alliance with Willis Healthcare to Improve Quality of Care in OB

February 9, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Feb. 9, 2011 /- PeriGen, Inc., the only OB-specific risk reduction company to provide solutions which generate immediate quantifiable clinical and financial value, today announced the formation of a strategic alliance with Willis Group Holdings (NYSE: WSH ), a leading...

Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience

February 8, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

DALLAS, Feb. 8, 2011 /- Targetbase , a leading U.S.-based direct marketing agency known for its expertise in understanding consumer data, translating that data into intelligence, and using it to produce effective creative with measurable results, today announced that Peter Dannenfelser...

New FDLI's Food and Drug Policy Forum Focuses on Liability Issues in Vaccine Design Defect Claims

February 8, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Feb. 8, 2011 /PRNewswire-USNewswire/ -- The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States,...

Advertisement

February 10 Town Hall Meeting to Explain DC's New Medical Marijuana Program

February 8, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Feb. 8, 2011 /PRNewswire-USNewswire/ -- The District of Columbia Patients Cooperative (DCPC), a taxable non-profit corporation that formed one year ago to provide high quality and affordable medical "marijuana" to qualifying DC patients will host a "Town Hall" meeting about...

Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery

February 6, 2011 11:35 pm | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., Feb. 7, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful...

Data on DermTech's Non-invasive Test for Melanoma Are Published in the British Journal of Dermatology

February 6, 2011 11:35 pm | by Bio-Medicine.Org | News | Comments

LA JOLLA, Calif., Feb. 7, 2011 /- DermTech International, Inc., a biotechnology company dedicated to bringing genomic medicine to dermatologists, today announced that the discovery data on its new genomic assay for melanoma have been published in the British Journal of Dermatology....

Elka Nir Joins VisionCare Board of Directors

February 5, 2011 6:35 pm | by Bio-Medicine.Org | News | Comments

SARATOGA, Calif., Feb. 5, 2011 /- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of end-stage age-related macular degeneration, today announced Elka Nir of Giza Venture Capital has joined VisionCare's Board of Directors. Ms....

Stiefel Launches Most-Prescribed BPO Wash Formulations Over-the-Counter

February 4, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Feb. 4, 2011 /- Stiefel, a GSK company, today announced the launch of the most-prescribed BPO Acne Wash formulations for over-the-counter (OTC) use in the United States. The launch will occur in the technical exhibit at the American Academy of Dermatology...

58% of Physicians Support FDA Move to Pull Breast Cancer Indication from Avastin

February 4, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Feb. 4, 2011 /- Sermo ( http://www.sermo.com ), the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the...

Photocure Announces Positive Allumeraâ„¢ Trial Results for Delivering Significant Skin Appearance Improvements

February 4, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

OSLO, Norway, Feb. 4, 2011 /- Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused in dermatology and cancer, today announced positive results from its consumer trial with Allumera™, a breakthrough cosmetic treatment formulated to improve the skin's appearance....

MEDfx to Harmonize the Direct Project With CONNECT

February 4, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

WARWICK, R.I., Feb. 4, 2011 /- MEDfx Corporation today announced a Direct Project pilot that demonstrates health information exchange among providers using a combination of the standards and protocols supported by the Direct Project and the FHA CONNECT Gateway. MEDfx is participating in,...

FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors

February 4, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

WAYNE, N.J., Feb. 4, 2011 /- Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumors (GIST) by the U.S. Food and Drug...

Carrot Medical Reports 2010 Growth in Sales and Financing, Optimism for 2011

February 3, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

BOSTON, Feb. 3, 2011 /- Carrot Medical, a leading designer of integrated medical imaging display systems, has announced results for 2010. During the year, Carrot Medical achieved significant growth in sales, an expansion of sales channels and secured additional private financing. Carrot...

Curemark Hosts New York Senator Kirsten Gillibrand

February 3, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

RYE, N.Y., Feb. 3, 2011 /- Curemark, LLC , ( www.curemark.com ), a drug research and development company focused on the treatment of neurological diseases, recently hosted New York Senator Kirsten Gillibrand as she announced a new proposal to spur innovation and job creation, locally and...

Hospira Announces FDA Approval of Topotecan Injection

February 3, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Feb. 3, 2011 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of Topotecan Injection, the first solution formulation of the oncology drug approved in the United...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading